Atreca - Antibody s Related Assets and Materials - Ownership and Business Overview

Life ScienceCompany

Atreca - Antibody s Related Assets and Materials Ownership

Who owns Atreca - Antibody s Related Assets and Materials?

Atreca - Antibody s Related Assets and Materials is owned by Immunome. It was acquired on December 26, 2023.

Atreca - Antibody s Related Assets and Materials Business Overview

Where is Atreca - Antibody s Related Assets and Materials headquartered?

Atreca - Antibody s Related Assets and Materials is headquartered in United States.

What sector is Atreca - Antibody s Related Assets and Materials in?

Atreca - Antibody s Related Assets and Materials is a life science company.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 206 acquisitions of life science companies in 2023, including 27 acquisitions by private equity firms, and 179 by strategics.

Atreca - Antibody's Related Assets and Materials

Atreca - Antibody's Related Assets and Materials


United States,

Atreca's Antibody's Related Assets and Materials are complementing the mission of developing innovative treatments for cancer patients.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Atreca - Antibody s Related Assets and Materials

Life Science Companies , United States Companies